Vpcir

1 known investors

VPCIR develops non-invasive lateral flow diagnostic test sticks that detect living pathogens in saliva, using patented Rolling Circle Amplification technology for point-of-care Tuberculosis testing. Its pipeline extends to other infectious diseases such as Malaria, targeting affordable, accessible diagnostics for global healthcare.

BiotechHealthtechMedical Devices